secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001104659-23-083084
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals enters $24M ATM equity offering with Cantor Fitzgerald
-----------------------------------------------------------------------------

- ATM sales agreement with Cantor Fitzgerald allows Hepion to sell up to $24M of common stock at market prices.
- Commission of 3.0% of gross proceeds paid to Cantor; Company provides customary indemnification.
- Shares sold under existing effective shelf registration statement (File No. 333-254996).
- No obligation to sell; offering terminates upon full issuance or termination of agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923083084/0001104659-23-083084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923083084/tm2321697d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-083084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer